Nancy Wysenski, EVP, Chief Commercial Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 5,000 shares at $28.90 ($145K) on 2011-12-12, disclosed to the SEC on 2011-12-13.
Scheduled sale ($144k) by EVP, Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ALKS | BUY | 2019-03-18 | $270K | — | Filing → |
| VRTX | SELL | 2012-06-01 | $11.6M | — | Filing → |
| VRTX | SELL | 2012-05-09 | $10.4M | — | Filing → |